Corgenix's lupus diagnostic:
This article was originally published in Clinica
Corgenix Medical has received US 510(k) clearance of its IgG Anti-AtherOx test kit. It will be used in patients with systemic lupus erythematosus (SLE) and lupus-like disorders such as antiphospholipid syndrome, to assess their risk of vascular injuries or thrombosis. The test is already CE marked for use in the EU, and Denver, Colorado-based Corgenix said that it is now available worldwide. Studies have shown that measurement of the AtherOx antibody was significantly better than conventional anti-cardiolipin testing, the firm said.